CDMOs

Novo completes $16.5bn takeover of Catalent
Pharmaphorum
Thu, 12/19/24 - 10:03 am
Novo Holdings
Catalent
CDMOs
M&A
Lonza plans to shed capsules business, simplify operating structure in push to become 'pure-play' CDMO
Fierce Pharma
Thu, 12/12/24 - 11:30 am
Lonza
CDMOs
drug manufacturing
With green light from European Commission, Novo Holdings' proposed $16.5B Catalent buyout nears close
Fierce Pharma
Sun, 12/8/24 - 09:37 pm
Novo Holdings
Catalent
Europe
M&A
CDMOs
Roche CEO says Novo's Catalent buyout 'could be a problem' for smaller drugmakers
Fierce Pharma
Wed, 10/23/24 - 10:26 pm
Roche
Novo Holdings
Catalent
CDMOs
M&A
drug manufacturing
CDMO Samsung Biologics bags $1.2B production contract, bringing total 2024 deal value to $3.3B+
Fierce Pharma
Wed, 10/23/24 - 11:20 am
Samsung BioLogics
CDMOs
South Korea
Radiopharma CDMO Nucleus lays out plan to triple manufacturing capacity, add 100 jobs
Fierce Pharma
Mon, 10/21/24 - 11:44 pm
CDMOs
Nucleus RadioPharma
cancer
Amid Novo Buy, Catalent Offloads New Jersey Facility to Ardena
BioSpace
Mon, 10/14/24 - 09:46 am
Catalent
CDMOs
drug manufacturing
New Jersey
Ardena
Biopharma prepares to pivot from China as Biosecure Act advances
Pharma Voice
Mon, 09/16/24 - 09:48 am
Biosecure Act
China
CROs
CDMOs
WuXi AppTec
Complete Genomics
MGI Tech
After sharp declines, Merck KGaA and analysts share optimism about potential CDMO rebound
Fierce Pharma
Wed, 08/7/24 - 11:00 pm
Merck KGaA
earnings
CDMOs
Scrutiny of WuXi Raises Potential Opportunities for Indian CDMOs
BioSpace
Wed, 07/3/24 - 11:18 am
China
India
Biosecure Act
CDMOs
Vanda rejects buyout offers, pans 'opportunistic attempts' at securing its shares at a discount
Fierce Pharma
Thu, 06/20/24 - 11:42 am
Vanda Pharmaceuticals
M&A
CDMOs
Future Pak
Cycle Pharmaceuticals
CordenPharma and Certest forge partnership to enhance drug delivery innovations
Biopharma Reporter
Mon, 06/10/24 - 11:21 am
CordenPharma
CDMOs
CerTest Biotec
drug delivery
Would BIO support a biosecurity bill targeting drug developers? Hear CEO John Crowley’s response
Fierce Pharma
Sun, 06/9/24 - 11:31 pm
BIO
biosecurity
CDMOs
Three Indian CDMOs ready to seize the BIOSECURE Act opportunity
Biopharma Reporter
Thu, 06/6/24 - 11:24 am
India
Biosecure Act
CDMOs
Merck KGaA's CDMO unit continues to slide but company sees an uptick coming
Fierce Pharma
Wed, 05/15/24 - 10:50 pm
Merck KGaA
CDMOs
Lonza, busy with capacity upgrades and exec turnover, hints at CDMO industry rebound
Fierce Pharma
Tue, 05/14/24 - 11:38 am
Lonza
CDMOs
COVID-19
CDMO Fujifilm Diosynth's restructuring plan may leave up to 240 staffers out of work
Fierce Pharma
Wed, 04/17/24 - 10:04 pm
CDMOs
layoffs
Fujifilm Diosynth Biotechnologies
Lonza adds biologics capacity with $1.2bn Roche deal
Pharmaphorum
Wed, 03/20/24 - 11:17 am
Roche
Lonza
drug manufacturing
Switzerland
CDMOs
Despite pharma growth, Merck KGaA's CDMO slowdown plays into company's overall sales decline
Fierce Pharma
Sun, 03/10/24 - 08:40 pm
Merck KGaA
earnings
CDMOs
Evotec Biologics expands partnership with ABL to develop antibodies against HIV
Biopharma Reporter
Mon, 02/12/24 - 11:10 pm
Evotec Biologics
ABL
CDMOs
HIV
antibodies

Pages